Hikma Pharmaceuticals Share Discussion Threads

[dartboard1] 25/2/2021 09:57

The problem with Hikma is they've actually grown revenue and profit in the past 12 months... you need to have shut down operations, made loads of redundancies and done a rights issue diluting a third of your capital to be trading at all time highs these days...

[robertball] 25/2/2021 09:43

Hmm..yes quality company. Good CEO (ex Teva) and motoring on with R&D, generics and acquisitions

[bennya] 25/2/2021 09:40

Sure, the sector is out of favour but quality always rises to the top. After this mornings blip I think the share price will recover quickly and get back on track

[bennya] 25/2/2021 08:16

Results looked ok to me, should start rising again soon

[robertball] 25/2/2021 08:12

GBP strength hitting earnings

[scepticalinvestor] 25/2/2021 07:59

not bad!didnt quite get my target buy in but should see st least 25 today

[robertball] 23/2/2021 08:35

This is right on the 15% trailing stop loss

[scepticalinvestor] 11/2/2021 16:06

Its quality.I have been watching this for a while since selling in the 2600p range.Hoping for a 2100p range to buy back in before results.

[peddlers] 11/2/2021 15:54

What a load of Tom Kite this stock is.

[robertball] 26/1/2021 08:41

I have faith in the CEO but this one has been tready water a bit. We will continue to wait and see.

[montyhedge] 26/1/2021 08:40

Looks like buying businesses off GSK.

[robertball] 26/1/2021 08:28

A bit of news might get this one moving again.

[montyhedge] 18/1/2021 11:13

How long delay, I wonder ?

[montyhedge] 16/1/2021 10:10

Generic Advair delayed, good news for GSK.

[scepticalinvestor] 12/1/2021 13:53

the irony is that the buy / sell ratio is 4:1

[robertball] 12/1/2021 12:35

No. COVID negativity maybe...

[scepticalinvestor] 12/1/2021 11:41

any ideas on this fall? VEC reported excellent results...

[thewheeliedealer] 26/12/2020 23:22

Hi all,

My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days before Xmas and part of our discussion includes HIK which I know C3 is keen on. We also chatted about loads of other Stocks and Ideas for research. We discussed the outlook for Markets and the most likely roadmap for the next couple of months, and as usual a fair bit of educational stuff with regards to Investing.

Anyway, if you use Youtube, Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 38) and you can find it on Soundcloud at the link below.

I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !!

Season’s Greetings !! WD
@wheeliedealer

[johnrxx99] 24/12/2020 07:52

I'd go for the cheapest whatever, as long as it's from a recognised producer. The price never remains the same.

[montyhedge] 23/12/2020 11:58

Of course but what you prefer the original for the same price has a generic version. The pie big enough for everyone, GSK not going to let companies eat their lunch.

[johnrxx99] 22/12/2020 04:43

What would the NHS do, buy a generic from a worldclass producer or the original for nearly double? What about the poor world, ie 80% of the world's population?

I know who my money would be on.

[montyhedge] 21/12/2020 11:55

I like Hik. All I'm saying the pie in Advair seems to me will be small for everyone, if undercutting goes on.

[suetballs] 21/12/2020 09:45

Well monty buy some hik to hedge your bets.
I own both shares.
Suet

[montyhedge] 21/12/2020 09:38

I'm sure GSK have there own cheap generic version out. If they all cut prices the cake will get smaller. GSK should blast the generics out the water.